Have you ever heard of Johnson & Johnson (ticker symbol: JNJ), a US stock?
It is a multinational company that deals in pharmaceuticals, medical devices, and other healthcare-related products.
In this article, I will introduce the company’s financial results for the period April to June 2021, which were announced on July 21, 2021.
Financial Results for April to June 2021
EPS of $2.48 vs. forecast of $2.29.
Net sales of $23.31 billion vs. forecast of $22.54 billion.
Sales growth rate was +27.1% YoY.
Consumer sales were $3.735 billion.
Pharmaceutical sales were $12.6 billion.
Medical Devices sales were $7.0 billion.